
Stratification tool IDs who will benefit from adding ezetimibe
(HealthDay)—For patients stabilized after acute coronary syndrome (ACS), a nine-point risk stratification tool can identify patients who will derive benefit from the addition of ezetimibe to statin therapy, according to ...
Feb 23, 2017
0
0